药师参与肝脓肿抗感染治疗方案优化的药学实践  

Pharmaceutical Practice for Anti-infection Treatment Optimization in Treatment of Liver Abscess by Pharmacists

作　　者：范璟蓉[1] 李莉[1] 方忠宏[1] 刘玉娟[1] 

机构地区：[1]复旦大学附属金山医院药剂科,上海200540

出　　处：《中国医院用药评价与分析》2016年第12期1717-1719,共3页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的:探讨药师参与肝脓肿抗感染治疗方案优化的药学实践。方法:针对1例肝脓肿患者,药师参与临床查房,在分析患者病情之后,根据抗菌药物的药效学特点,建议用美洛西林舒巴坦取代头孢吡肟、左氧氟沙星与甲硝唑的联合用药,临床医师采纳了建议。结果:更改抗感染治疗方案后,疗效得到了保证,且药品不良反应减少,抗菌药物使用强度降低。结论:临床药师参与临床药物治疗,发挥自身药学专长,提供药学服务,可促进医疗质量的提高。OBJECTIVE： To probe into the pharmaceutical practice for anti-infection treatment optimization in treatment of liver abscess by pharmacists. METHODS： Pharmacists participated in clinical ward rounds. After examining the ill condition of the patient with liver abscess,according to the pharmacodynamic characteristics of antimicrobial agents,the pharmacists suggested that the drug combination of cefepime,levofloxacin and metronidazole should be replaced by mezlocillin and sulbactam. The clinicians adopt the proposal. RESULTS： After the change of anti-infection treatment,the quality of medical care was assured,the adverse drug reactions were reduced,and the intensity of the antibacterial medicine also decreased. CONCLUSIONS： The clinical pharmacists participate into the clinical treatment,play their pharmaceutical specialty and provide pharmaceutical care can promote the improvement of medical quality.

关 键 词：临床药师 药物性肝损害 肝脓肿 甲硝唑 头孢吡肟 抗菌药物使用强度 

分 类 号：R978.1[医药卫生—药品]